Microdosing GLP-1 weight loss drugs like semaglutide is trendy, with supporters touting benefits such as lower costs and potentially fewer side effects. But some doctors are skeptical, calling it ...
Hosted on MSN
Coherus Biosciences Divests UDENYCA Business
An update from Coherus Biosciences ( (CHRS)) is now available. On April 11, 2025, Coherus Biosciences sold its UDENYCA business, marking a significant divestiture of its biosimilar businesses, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback